# AptaPharma Inc. - Inspection Records

Source: https://www.keypedia.com/companies/aptapharma-inc/8390ea00-697d-4f5d-9e50-407830a6b2ee

> Inspection records and compliance data for AptaPharma Inc. in Pennsauken, New Jersey. Access full analysis and detailed observations.

---

## Details

- Name: AptaPharma Inc.
- FEI Number: 3010164738
- City: Pennsauken
- State: New Jersey
- Country Name: United States
- Address Line 1: 1533 Union Ave
- Zip Code: 08110
- Business Operations: FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1231140 - AptaPharma Inc. - 2024-10-24](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/6aa72e07-3da7-4980-8ab9-23ac21eb4f6f) — source: FDA, date: October 24, 2024
- [FDA Inspection 1231140 - AptaPharma Inc. - 2024-10-24](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/137899a3-a9c7-4739-8a69-df8e78f3e86c) — classification: No Action Indicated (NAI), source: FDA, date: October 24, 2024
- [483 - AptaPharma Inc. - 2023-05-15](https://www.keypedia.com/records/483/aptapharma-inc/c030fb89-e748-43a8-a12b-56e31d0a48aa) — source: FDA, date: May 15, 2023
- [483 - AptaPharma Inc. - 2019-09-25](https://www.keypedia.com/records/483/aptapharma-inc/bee3d493-6ce7-4c04-8af5-2007f5919b47) — source: FDA, date: September 25, 2019
- [FDA Inspection 1102699 - AptaPharma Inc. - 2019-09-25](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/412628c1-3ed7-4ab7-afc9-0f5453b9d583) — classification: No Action Indicated (NAI), source: FDA, date: September 25, 2019
- [483 - AptaPharma Inc. - 2018-03-16](https://www.keypedia.com/records/483/aptapharma-inc/b8e498cb-6750-4e19-b7cd-a3cd4a19c5e5) — source: FDA, date: March 16, 2018
- [EIR - AptaPharma Inc. - 2018-03-16](https://www.keypedia.com/records/eir/aptapharma-inc/1dda210d-9101-42ce-aca7-33184b05f30e) — source: FDA, date: March 16, 2018
- [FDA Inspection 1045668 - AptaPharma Inc. - 2018-03-16](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/56b08717-7de1-4c2d-9b87-592490ed7578) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 16, 2018
- [FDA Inspection 884304 - AptaPharma Inc. - 2014-06-23](https://www.keypedia.com/records/fda_inspections/aptapharma-inc/05107648-0655-47e0-b223-f61ba95cd7cc) — classification: No Action Indicated (NAI), source: FDA, date: June 23, 2014

## Related Companies

- [LS Promotions Inc.](https://www.keypedia.com/companies/ls-promotions-inc/9825ac21-f1b0-4b9d-8a4a-ceaf3b5848f6)
- [Owen Biosciences Inc.](https://www.keypedia.com/companies/owen-biosciences-inc/a884ad6d-40ba-4df7-8385-49f52b3dff62)
- [B & J Group](https://www.keypedia.com/companies/b-j-group/d182d7fa-aaf8-48b6-88fa-11beafc5345e)
- [J.M. Murray Center, Inc.](https://www.keypedia.com/companies/jm-murray-center-inc/c8ea2d08-6e27-4aab-956c-49bafd74acf7)
- [Bio-Medical Pharmaceutical Manufacturing Corporation](https://www.keypedia.com/companies/bio-medical-pharmaceutical-manufacturing-corporation/ff03af78-b7e9-4d7f-97ba-78089c6ee119)
- [Safecor Health, LLC](https://www.keypedia.com/companies/safecor-health-llc/b344a811-7abf-44a5-8723-cd4a89227440)
- [Aerosol and Liquid Packaging, Inc.](https://www.keypedia.com/companies/aerosol-and-liquid-packaging-inc/8e294e83-8cfc-40e9-8f8d-e49012a062de)
- [Darmerica, LLC](https://www.keypedia.com/companies/darmerica-llc/ff6fa87e-2dbc-4215-a76f-630e5e1c9030)
- [NWL Netherlands Services B.V.](https://www.keypedia.com/companies/nwl-netherlands-services-bv/b48400c5-c5c3-473b-86ca-24699f824d1c)
- [Medi-Fare Drug](https://www.keypedia.com/companies/medi-fare-drug/6fa558e8-65a8-455f-9f05-ea8f53028ea4)

## Related Officers

- [Advisor](https://www.keypedia.com/people/frederick-razzaghi/7346f6ec-1d9a-4ad3-abde-0497dcd9c8b5)
- [company_representative](https://www.keypedia.com/people/rakesh-lad/d0792d2d-8d57-4397-ac03-34446ccf9523)
- [Investigator](https://www.keypedia.com/people/nancy-m-espinal/f4494790-6a37-4998-853c-f859a0eb3330)